This Prize, amounting to 75.000 €, is a triennial and international Prize, granted by “Fonds de la Recherche Scientifique – FNRS” (F.R.S.-FNRS) to reward a scientist or a medical doctor, in recognition of a research work which has contributed to the treatment of a disease currently incurable, or which has raised hopes for curing the disease.

The 2021 Prize was awarded to Prof. Guillaume Canaud of the Necker Hospital, University of Paris, for his contributions to the therapeutic treatment of PIK3CA-related overgrowth spectrum (PROS), which includes a broad range of rare disorders caused by a PIK3CA mutation.